Active-ingredient Dossier
Exemestane
Active-ingredient Dossier for Exemestane (aromatase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: AROMASIN
- Brand: APO-EXEMESTANE
- Brand: EXEMESTANE
- Brand: EXEMESTANE
- Brand: EXEMESTANE-WGR
- Brand: EXEMEST
- Therapeutic area: Oncology
What is
Exemestane Exemestane is an aromatase inhibitor.
Therapeutic areas
Exemestane is registered in oncology, with 8 brands containing this ingredient on the ARTG.
Sponsor landscape
Exemestane is marketed by seven sponsors: Accord Healthcare, Arrotex Pharmaceuticals, Pfizer, Sandoz, Southern Cross Pharma, and Generic Health.
PBS and regulatory activity
One brand containing exemestane has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 March 2022.